| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/15/2009 | WO2008137591A3 Non-invasive detection of endometrial cancer |
| 01/15/2009 | WO2008131224A3 Diabetes-related biomarkers and methods of use thereof |
| 01/15/2009 | WO2008128730A3 Antagonists of bitter taste receptors and uses thereof |
| 01/15/2009 | WO2008124916A8 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging |
| 01/15/2009 | WO2008124091A3 Compositions and methods of detection |
| 01/15/2009 | WO2008122793A3 Blood group antibody screening |
| 01/15/2009 | WO2008119081A8 System and method for high resolution analysis of nucleic acids to detect sequence variations |
| 01/15/2009 | WO2008113013A3 C-met mutations and uses thereof |
| 01/15/2009 | WO2008104803A3 Proteins |
| 01/15/2009 | WO2008098236A3 Droplet actuator devices and methods employing magnetic beads |
| 01/15/2009 | WO2008089073A3 Combinatorial libraries of conformationally constrained polypeptide sequences |
| 01/15/2009 | WO2008071679A9 Fibrin binding peptide conjugates for diagnostic and therapeutic applications. |
| 01/15/2009 | WO2008063310A3 Use of cell surface displays in yeast cell catalyst supports |
| 01/15/2009 | WO2008052775A3 Click chemistry for the production of reporter molecules |
| 01/15/2009 | WO2008049422A3 Risk stratification for acute coronary syndrome by means of fragments/partial peptides of provasopressin, especially copeptin or neurophysin ii |
| 01/15/2009 | WO2008021408A3 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 01/15/2009 | WO2008017598A3 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
| 01/15/2009 | WO2007047924A4 Improved target ligand detection |
| 01/15/2009 | US20090019558 Pgds as modifiers of the pten pathway and methods of use |
| 01/15/2009 | US20090019557 Fgf2-related methods for diagnosing and treating depression |
| 01/15/2009 | US20090019556 Oasis gene-deficient mouse |
| 01/15/2009 | US20090018870 Method for Preventing Chronic Disease |
| 01/15/2009 | US20090018780 Hazardous Substance Release Notification System |
| 01/15/2009 | US20090018776 System and method for normalizing data in nucleic acid amplification procedures |
| 01/15/2009 | US20090018413 Implantable medical device for diagnostic sensing |
| 01/15/2009 | US20090018312 Igf-1 receptor interacting proteins |
| 01/15/2009 | US20090018161 Method for promoting gastrointestinal function and method for screening for promoter of gastrointestinal function |
| 01/15/2009 | US20090018149 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections |
| 01/15/2009 | US20090018142 Use of phosphatases to treat tumors overexpressing N-CoR |
| 01/15/2009 | US20090018110 Haptoglobin genotyping for prognosis and treatment of chronic vasospasm following subarachnoid hemorrhage (SAH) |
| 01/15/2009 | US20090018101 S-adenosyl-l-methionine analogs with extended activated groups for transfer by methyltransferases |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018072 High protein supplement |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018030 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 01/15/2009 | US20090018029 Methods and Compositions Comprising Non-Natural Amino Acids |
| 01/15/2009 | US20090018025 Testing Method of Nucleic Acid Binding Protein Based on Biochip |
| 01/15/2009 | US20090017562 Raman-active reagents |
| 01/15/2009 | US20090017561 Labelled silica nanoparticles for immunochromatographic reagent, immunochromatographic reagent, immunochromatographic test strip using the same, and immunochromatographic fluorescence-detecting system or radiation-detecting system |
| 01/15/2009 | US20090017560 Cardiovascular autoimmune disease panel and methods of using same |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017558 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 01/15/2009 | US20090017557 FVII Specific Antibodies and Use Thereof |
| 01/15/2009 | US20090017556 Methods and complexes involving immunoglobulin molecule |
| 01/15/2009 | US20090017555 Delta-9-tetrahydrocannabinol detection method |
| 01/15/2009 | US20090017551 Method and device for the detection of hydrogen |
| 01/15/2009 | US20090017550 Method For Determining A Carbon Source Of A Product |
| 01/15/2009 | US20090017549 electrochemically reducing the known iodine-containing organic compound in an aqueous medium to release iodide anions, chemically oxidizing the iodide anions to produce molecular iodine, and measuring the amount of molecular iodine; for measurement of glomerular filtration rate |
| 01/15/2009 | US20090017548 for treatment and prevention of plaque accumulation; chromatography, assay |
| 01/15/2009 | US20090017547 Systems and methods for dna computing using methylation |
| 01/15/2009 | US20090017546 Fluorescent isotope tags and their method of use |
| 01/15/2009 | US20090017537 hT2R54 Receptor Polypeptides and Nucleic Acid Sequences |
| 01/15/2009 | US20090017534 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
| 01/15/2009 | US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction |
| 01/15/2009 | US20090017521 Chimaeric phages |
| 01/15/2009 | US20090017494 Tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/15/2009 | US20090017492 SVPH1-26 DNA and polypeptides |
| 01/15/2009 | US20090017486 Method and test kit for the identification of compounds specifically modulating the action of cortical axo-axonic cells |
| 01/15/2009 | US20090017485 Alzheimer's Disease Examination Method |
| 01/15/2009 | US20090017484 Markers for atherosclerosis |
| 01/15/2009 | US20090017482 Luminogenic and nonluminogenic multiplex assay |
| 01/15/2009 | US20090017480 Detecting causative agent of Johne's disease (Mycobacterium avium subsp. paratuberculosis) via enhanced Raman Spectroscopy; heat treatment; immunoassay; kits |
| 01/15/2009 | US20090017479 Ly6h gene |
| 01/15/2009 | US20090017478 High-throughput enzyme-linked immuno absorbent assay (elisa) for determination of rho-kinase (rok) activity |
| 01/15/2009 | US20090017477 Method for determination of concentration, charge or unit size of a substance |
| 01/15/2009 | US20090017476 Multiple Component Nanoparticles for Multiplexed Signaling and Optical Encoding |
| 01/15/2009 | US20090017475 Method to Determine Pseudo-Allergic Reactions |
| 01/15/2009 | US20090017474 Systems and methods for detecting abnormal cells |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017472 BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNFalpha INHIBITORS IN AUTOIMMUNE DISORDERS |
| 01/15/2009 | US20090017471 SOLUBLE ErbB3 METHOD OF DETECTION |
| 01/15/2009 | US20090017470 Immunological analytical reagent for the determination of advance glycosylation end products (AGEs) |
| 01/15/2009 | US20090017469 Use of Holographic Sensor |
| 01/15/2009 | US20090017468 Method of screening compound directly activating glycogen synthase |
| 01/15/2009 | US20090017467 COMPOSITION EXHIBITING A VON WILLEBRAND FACTOR (vWF) PROTEASE ACTIVITY COMPRISING A POLYPEPTIDE CHAIN WITH THE AMINO ACID SEQUENCE AAGGILHLELLV |
| 01/15/2009 | US20090017466 Separation-free assay method |
| 01/15/2009 | US20090017463 Methods for predicting prostate cancer recurrence |
| 01/15/2009 | US20090017461 Diagnosis of Gynecological Neoplasms by Detecting the Levels of Oviduct-Specific Glycoprotein |
| 01/15/2009 | US20090017457 Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents |
| 01/15/2009 | US20090017454 Biosensors, method for obtaining the same and uses thereof |
| 01/15/2009 | US20090017446 Method and Set of Tools for Checking the Crystallisation Conditions of Biological Macromolecules |
| 01/15/2009 | US20090017443 Method for Detection of Hepatitus B Virus |
| 01/15/2009 | US20090017173 Automatic process control of conveyorized ovens for improved baking efficiency and product uniformity |
| 01/15/2009 | US20090017171 Proof and pan dough template system |
| 01/15/2009 | US20090017157 Population of dairy cows producing milk with desirable characteristics and methods of making and using same |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017073 Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
| 01/15/2009 | US20090017061 Mycobacteria with Mannose Cap-Deficient Lipoarabinomannan |
| 01/15/2009 | US20090017051 Allergy vaccines and their preparation |
| 01/15/2009 | US20090017050 Egfr antigen-binding molecules and uses thereof |
| 01/15/2009 | US20090017048 Novel Brachyspira hyodysenteriae vaccine |
| 01/15/2009 | US20090017046 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents; administering an antibody or antigen binding fragment thereof that specifically binds to upregulated OX-2/CD200 |
| 01/15/2009 | US20090017041 Monoclonal antibody |
| 01/15/2009 | US20090017040 Monoclonal antibody |
| 01/15/2009 | US20090017038 Sigma-2 Receptor, Method of Screening of Specific Ligands and Use of the Same in Diagnostic or Therapeutic Methods |
| 01/15/2009 | US20090017037 Human TIMP-1 Antibodies |
| 01/15/2009 | US20090017033 Inhibiting receptor activated nuclear factor kappa beta ligand (RANKL); immunoregulation |
| 01/15/2009 | US20090017032 Mammalian cx3c chemokine antibodies |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |